FINVX
Price
$16.77
Change
+$0.06 (+0.36%)
Updated
Jun 2 closing price
Net Assets
17.81B
TRWFX
Price
$28.44
Change
+$0.17 (+0.60%)
Updated
Jun 2 closing price
Net Assets
4.32B
Interact to see
Advertisement

FINVX vs TRWFX

Header iconFINVX vs TRWFX Comparison
Open Charts FINVX vs TRWFXBanner chart's image
FINVX vs TRWFX Comparison Chart in %
View a ticker or compare two or three
VS
FINVX vs. TRWFX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FINVX is a StrongBuy and TRWFX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FINVX has more cash in the bank: 17.8B vs. TRWFX (4.32B). FINVX pays higher dividends than TRWFX: FINVX (4.06) vs TRWFX (3.23). FINVX was incepted earlier than TRWFX: FINVX (17 years) vs TRWFX (9 years). TRWFX (1.01) is less costly to investors than FINVX (0.01). FINVX is a more actively managed with annual turnover of: 29.00 vs. TRWFX (13.00). FINVX has a lower initial minimum investment than TRWFX: FINVX (0) vs TRWFX (5000). TRWFX annual gain was more profitable for investors over the last year : 20.34 vs. FINVX (15.70). FINVX return over 5 years is better than : 76.52 vs. TRWFX (45.25).
FINVXTRWFXFINVX / TRWFX
Total Expense Ratio0.011.011%
Annual Report Gross Expense Ratio0.011.011%
Fund Existence17 years9 years-
Gain YTD7.11511.87260%
Front LoadN/AN/A-
Min. Initial Investment05000-
Min. Initial Investment IRAN/AN/A-
Net Assets17.8B4.32B412%
Annual Yield % from dividends4.063.23126%
Returns for 1 year15.7020.3477%
Returns for 3 years74.6456.17133%
Returns for 5 years76.5245.25169%
Returns for 10 years134.54N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PCSA2.920.39
+15.42%
Processa Pharmaceuticals Inc.
ALRS28.920.45
+1.58%
Alerus Financial Corp
STZ136.760.51
+0.37%
Constellation Brands
GBDC13.27-0.09
-0.67%
Golub Capital BDC
SPRB49.40-1.30
-2.56%
Spruce Biosciences Inc